Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2474 | 3972 | 39.3 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
116 | 3 | MUTATION RESEARCH//TOXICOLOGY//CARCINOGENESIS | 70215 |
2474 | 2 | ABERRANT CRYPT FOCI//ANTINEOPLASTIC DRUGS//COLON CARCINOGENESIS | 3972 |
3627 | 1 | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL//RED MEAT//ECP UK HEADQUARTERS | 1941 |
13800 | 1 | ANTINEOPLASTIC DRUGS//HAZARDOUS DRUGS//TOXICITY ENVIRONMENTAL | 812 |
18307 | 1 | ABERRANT CRYPT FOCI//COLON CARCINOGENESIS//AZOXYMETHANE | 557 |
27135 | 1 | MICROSOMAL FATTY ACID COMPOSITION//SALMONELLA MUTAGENICITY SPIRAL ASSAY//AND DIETARY OILS | 236 |
29507 | 1 | CALCIUM GLUCARATE//MAHARISHI 4//D GLUCARIC ACID | 185 |
29803 | 1 | FECAPENTAENES//FECAPENTAENE 12//FP 12 | 179 |
37263 | 1 | PHENOBARBITAL HYDROCORTISONE//COLORECTAL TUMOR TISSUE//SENSITIVITY TO HORMONES | 62 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ABERRANT CRYPT FOCI | authKW | 423151 | 4% | 38% | 146 |
2 | ANTINEOPLASTIC DRUGS | authKW | 179275 | 2% | 33% | 71 |
3 | COLON CARCINOGENESIS | authKW | 94141 | 1% | 22% | 57 |
4 | AZOXYMETHANE | authKW | 75071 | 1% | 19% | 51 |
5 | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | journal | 73731 | 4% | 6% | 161 |
6 | 1 2 DIMETHYLHYDRAZINE | authKW | 52418 | 1% | 21% | 32 |
7 | HAZARDOUS DRUGS | authKW | 49186 | 0% | 80% | 8 |
8 | ABERRANT CRYPTS | authKW | 46827 | 0% | 38% | 16 |
9 | COLON CANC PREVENT PROGRAM | address | 44274 | 0% | 52% | 11 |
10 | BETA CATENIN ACCUMULATED CRYPTS | authKW | 41842 | 0% | 78% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 21214 | 38% | 0% | 1523 |
2 | Nutrition & Dietetics | 10217 | 14% | 0% | 549 |
3 | Toxicology | 4600 | 11% | 0% | 429 |
4 | Public, Environmental & Occupational Health | 2831 | 12% | 0% | 479 |
5 | Gastroenterology & Hepatology | 2181 | 8% | 0% | 310 |
6 | Pharmacology & Pharmacy | 469 | 9% | 0% | 356 |
7 | Genetics & Heredity | 337 | 5% | 0% | 210 |
8 | Pathology | 102 | 2% | 0% | 86 |
9 | Medicine, General & Internal | 92 | 4% | 0% | 161 |
10 | Nursing | 89 | 1% | 0% | 47 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | COLON CANC PREVENT PROGRAM | 44274 | 0% | 52% | 11 |
2 | ECP UK HEADQUARTERS | 27664 | 0% | 60% | 6 |
3 | CRI 9505 | 16006 | 0% | 42% | 5 |
4 | COLON POLYPS COLON CANC | 15372 | 0% | 100% | 2 |
5 | JR AGR NUTR SETAGAYA KU | 15372 | 0% | 100% | 2 |
6 | NUTR HISTOPATHOL AGEING | 15372 | 0% | 100% | 2 |
7 | S IR MED SURG B | 15372 | 0% | 100% | 2 |
8 | TORONTO BRANCH 9 EARL ST | 15372 | 0% | 100% | 2 |
9 | EUROPEAN CANC PREVENT ORG | 15368 | 0% | 50% | 4 |
10 | NUTR HLTH PROGRAMME | 13659 | 0% | 44% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 73731 | 4% | 6% | 161 |
2 | EUROPEAN JOURNAL OF CANCER PREVENTION | 21304 | 2% | 4% | 69 |
3 | CARCINOGENESIS | 16349 | 4% | 1% | 158 |
4 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 13067 | 3% | 2% | 104 |
5 | CANCER LETTERS | 11582 | 3% | 1% | 136 |
6 | MUTATION RESEARCH | 11304 | 3% | 1% | 110 |
7 | AMERICAN JOURNAL OF HOSPITAL PHARMACY | 9516 | 1% | 2% | 55 |
8 | JOURNAL OF THE NATIONAL CANCER INSTITUTE | 6135 | 2% | 1% | 63 |
9 | CANCER RESEARCH | 5390 | 4% | 0% | 169 |
10 | INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH | 4706 | 1% | 1% | 45 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ABERRANT CRYPT FOCI | 423151 | 4% | 38% | 146 | Search ABERRANT+CRYPT+FOCI | Search ABERRANT+CRYPT+FOCI |
2 | ANTINEOPLASTIC DRUGS | 179275 | 2% | 33% | 71 | Search ANTINEOPLASTIC+DRUGS | Search ANTINEOPLASTIC+DRUGS |
3 | COLON CARCINOGENESIS | 94141 | 1% | 22% | 57 | Search COLON+CARCINOGENESIS | Search COLON+CARCINOGENESIS |
4 | AZOXYMETHANE | 75071 | 1% | 19% | 51 | Search AZOXYMETHANE | Search AZOXYMETHANE |
5 | 1 2 DIMETHYLHYDRAZINE | 52418 | 1% | 21% | 32 | Search 1+2+DIMETHYLHYDRAZINE | Search 1+2+DIMETHYLHYDRAZINE |
6 | HAZARDOUS DRUGS | 49186 | 0% | 80% | 8 | Search HAZARDOUS+DRUGS | Search HAZARDOUS+DRUGS |
7 | ABERRANT CRYPTS | 46827 | 0% | 38% | 16 | Search ABERRANT+CRYPTS | Search ABERRANT+CRYPTS |
8 | BETA CATENIN ACCUMULATED CRYPTS | 41842 | 0% | 78% | 7 | Search BETA+CATENIN+ACCUMULATED+CRYPTS | Search BETA+CATENIN+ACCUMULATED+CRYPTS |
9 | TOXICITY ENVIRONMENTAL | 38901 | 0% | 56% | 9 | Search TOXICITY+ENVIRONMENTAL | Search TOXICITY+ENVIRONMENTAL |
10 | FECAPENTAENES | 38429 | 0% | 100% | 5 | Search FECAPENTAENES | Search FECAPENTAENES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PARODI, PW , (2001) AN ASSESSMENT OF THE EVIDENCE LINKING CALCIUM AND VITAMIN D TO COLON CANCER PREVENTION.AUSTRALIAN JOURNAL OF DAIRY TECHNOLOGY. VOL. 56. ISSUE 1. P. 38 -58 | 135 | 66% | 3 |
2 | TURCI, R , SOTTANI, C , SPAGNOLI, G , MINOIA, C , (2003) BIOLOGICAL AND ENVIRONMENTAL MONITORING OF HOSPITAL PERSONNEL EXPOSED TO ANTINEOPLASTIC AGENTS: A REVIEW OF ANALYTICAL METHODS.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 789. ISSUE 2. P. 169-209 | 94 | 70% | 74 |
3 | HUNCHAREK, M , MUSCAT, J , KUPELNICK, B , (2009) COLORECTAL CANCER RISK AND DIETARY INTAKE OF CALCIUM, VITAMIN D, AND DAIRY PRODUCTS: A META-ANALYSIS OF 26,335 CASES FROM 60 OBSERVATIONAL STUDIES.NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL. VOL. 61. ISSUE 1. P. 47 -69 | 59 | 79% | 102 |
4 | SZILAGYI, A , NATHWANI, U , VINOKUROFF, C , CORREA, JA , SHRIER, I , (2006) THE EFFECT OF LACTOSE MALDIGESTION ON THE RELATIONSHIP BETWEEN DAIRY FOOD INTAKE AND COLORECTAL CANCER: A SYSTEMATIC REVIEW.NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL. VOL. 55. ISSUE 2. P. 141 -150 | 77 | 80% | 4 |
5 | PRETLOW, TP , PRETLOW, TG , (2005) MUTANT KRAS IN ABERRANT CRYPT FOCI (ACF): INITIATION OF COLORECTAL CANCER?.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1756. ISSUE 2. P. 83-96 | 86 | 64% | 61 |
6 | ASTORG, P , BOUTRON-RUOULT, MC , ANDRIEUX, C , ASTORG, P , BLACHIER, F , BLOTTIERE, H , BONITHON-KOPP, C , BOUTRON-RUAULT, MC , CASSAND, P , CHAUMONTET, C , ET AL (2002) DIETARY FIBERS AND COLORECTAL CANCER. EXPERIMENTAL STUDIES, EPIDEMIOLOGY, MECHANISMS.GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE. VOL. 26. ISSUE 10. P. 893-912 | 118 | 55% | 6 |
7 | SONG, MY , GARRETT, WS , CHAN, AT , (2015) NUTRIENTS, FOODS, AND COLORECTAL CANCER PREVENTION.GASTROENTEROLOGY. VOL. 148. ISSUE 6. P. 1244 -U217 | 132 | 26% | 19 |
8 | MCDIARMID, MA , CONNOR, TH , (2006) PREVENTING OCCUPATIONAL EXPOSURES TO ANTINEOPLASTIC DRUGS IN HEALTH CARE SETTINGS.CA-A CANCER JOURNAL FOR CLINICIANS. VOL. 56. ISSUE 6. P. 354-365 | 51 | 96% | 59 |
9 | MARIE, P , CHRISTOPHE, C , MANON, R , MARC, M , CHARLERIC, B , PATRICE, V , (2017) ENVIRONMENTAL MONITORING BY SURFACE SAMPLING FOR CYTOTOXICS: A REVIEW.ENVIRONMENTAL MONITORING AND ASSESSMENT. VOL. 189. ISSUE 2. P. - | 47 | 89% | 0 |
10 | BAKER, ES , CONNOR, TH , (1996) MONITORING OCCUPATIONAL EXPOSURE TO CANCER CHEMOTHERAPY DRUGS.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 53. ISSUE 22. P. 2713-2723 | 81 | 86% | 43 |
Classes with closest relation at Level 2 |